These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2258013)

  • 1. The in vitro activation of cyclophosphamide in the Hydra Developmental Toxicology Assay.
    Newman LM; Johnson EM; Giacobbe RL; Fu LJ
    Fundam Appl Toxicol; 1990 Oct; 15(3):488-99. PubMed ID: 2258013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism and binding of cyclophosphamide and its metabolite acrolein to rat hepatic microsomal cytochrome P-450.
    Marinello AJ; Bansal SK; Paul B; Koser PL; Love J; Struck RF; Gurtoo HL
    Cancer Res; 1984 Oct; 44(10):4615-21. PubMed ID: 6380709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cooxidation of cyclophosphamide as an alternative pathway for its bioactivation and lung toxicity.
    Smith RD; Kehrer JP
    Cancer Res; 1991 Jan; 51(2):542-8. PubMed ID: 1985772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a metabolic activation system for the frog embryo teratogenesis assay: Xenopus (FETAX).
    Fort DJ; Dawson DA; Bantle JA
    Teratog Carcinog Mutagen; 1988; 8(5):251-63. PubMed ID: 2905834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competitive inhibition of human liver microsomal cytochrome P450 3A-dependent steroid 6 beta-hydroxylation activity by cyclophosphamide and ifosfamide in vitro.
    Murray M; Butler AM; Stupans I
    J Pharmacol Exp Ther; 1994 Aug; 270(2):645-9. PubMed ID: 8071856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug metabolizing enzymes in Drosophila melanogaster: teratogenicity of cyclophosphamide in vitro.
    Bournias-Vardiabasis N; Flores J
    Teratog Carcinog Mutagen; 1983; 3(3):255-62. PubMed ID: 6137081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the induction of hepatic microsomal metabolism on the toxicity of cyclophosphamide.
    Gurtoo HL; Bansal SK; Pavelic Z; Struck RF
    Br J Cancer; 1985 Jan; 51(1):67-75. PubMed ID: 3966972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of uninduced rat liver S-9 to supplement BALB/3T3 cells in the in vitro transformation assay.
    Sheu CJ; Lee JK; Rodriguez I; Randolph SC
    Drug Chem Toxicol; 1991; 14(1-2):113-26. PubMed ID: 1889371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rapid in vitro method for the evaluation of potential antitumor drugs requiring metabolic activation by hepatic S9 enzymes.
    Lebsanft J; McMahon JB; Steinmann GG; Shoemaker RH
    Biochem Pharmacol; 1989 Dec; 38(24):4477-83. PubMed ID: 2604748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclophosphamide metabolism in the primary immune organs of the chick: assays of drug activation, P450 expression, and aldehyde dehydrogenase.
    Misra RR; Lorr NA; Bloom SE
    Arch Toxicol; 1991; 65(1):32-8. PubMed ID: 2043048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic activation in the fetal mouse salivary gland culture system with rat hepatocytes, rat S-9, and human S-9.
    Lyng RD; Scalf R; Monteith D
    Teratog Carcinog Mutagen; 1991; 11(1):31-9. PubMed ID: 1677496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro testing for developmental toxicity using the Hydra attenuata assay.
    Wiger R; Støttum A
    NIPH Ann; 1985 Dec; 8(2):43-7. PubMed ID: 2417165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the mechanism by which cyclophosphamide alters cytochrome P450 in male rats.
    McClure MT; Stupans I
    Biochem Pharmacol; 1992 Jun; 43(12):2655-8. PubMed ID: 1632821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the developmental toxicity of chlorinated phenols utilizing Hydra attenuata and postimplantation rat embryos in culture.
    Mayura K; Smith EE; Clement BA; Phillips TD
    Toxicol Appl Pharmacol; 1991 Apr; 108(2):253-66. PubMed ID: 2017755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics, metabolic activation, and lung toxicity of cyclophosphamide in C57/B16 and ICR mice.
    Kanekal S; Fraiser L; Kehrer JP
    Toxicol Appl Pharmacol; 1992 May; 114(1):1-8. PubMed ID: 1585362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-culture of rat embryos and hepatocytes: in vitro detection of a proteratogen.
    Oglesby LA; Ebron MT; Beyer PE; Carver BD; Kavlock RJ
    Teratog Carcinog Mutagen; 1986; 6(2):129-38. PubMed ID: 2874641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of two cytotoxicity assays for the detection of metabolism-mediated toxicity in vitro: a study with cyclophosphamide.
    Horner SA; Fry JR; Clothier RH; Balls M
    Xenobiotica; 1985; 15(8-9):681-6. PubMed ID: 3878046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the developmental toxicity of five compounds with the frog embryo teratogenesis assay: Xenopus (FETAX) and a metabolic activation system.
    Fort DJ; James BL; Bantle JA
    J Appl Toxicol; 1989 Dec; 9(6):377-88. PubMed ID: 2613998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vitro teratogenicity of cyclophosphamide in rat embryos.
    Greenaway JC; Fantel AG; Shepard TH; Juchau MR
    Teratology; 1982 Jun; 25(3):335-43. PubMed ID: 7112435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxic effects of cyclophosphamide in differentiating chicken limb bud cell culture using rat liver 9,000 g supernatant or rat liver cells as an activation system: an in vitro short-term test for proteratogens.
    Wiger R; Trygg B; Holme JA
    Teratology; 1989 Dec; 40(6):603-13. PubMed ID: 2623647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.